No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹594Prev. Close
₹595.1Turnover(Lac.)
₹221.26Day's High
₹601.1Day's Low
₹587.252 Week's High
₹687.252 Week's Low
₹278.2Book Value
₹373.14Face Value
₹2Mkt Cap (₹ Cr.)
4,169.08P/E
0EPS
0Divi. Yield
020 Jun 2025
12:00 AM
AGM
Announcement Date: 20 Jun, 2025
6 May 2026
12:00 AM
Board Meeting
Agenda : Audited Result
Here are some of the stocks that may see significant price movement today: Texmaco Rail, Vedanta, Unichem Laboratories, etc.
Revenue increased by 14.5% to ₹533 crore from ₹466 crore the previous year.
Bayshore Pharmaceuticals is a 100% subsidiary of Unichem Laboratories' parent firm, Ipca Laboratories Ltd.
According to the corporation, the observations have no influence on business continuity or supplies to the US market.
Here are some of the stocks that may see significant price movement today: Hindustan Unilever, Birla Estates, Lupin, etc.
| Y/e 31 Mar( In .Cr) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 |
|---|---|---|---|---|
Equity Capital | 14.08 | 14.08 | 14.08 | 14.08 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2,613.02 | 2,445.67 | 2,280.55 | 2,370.19 |
Net Worth | 2,627.1 | 2,459.75 | 2,294.63 | 2,384.27 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 942.92 | 1,123.97 | 904.88 | 669.33 |
yoy growth (%) | -16.1 | 24.21 | 35.19 | 16.19 |
Raw materials | -383.47 | -432.94 | -382.75 | -350.68 |
As % of sales | 40.66 | 38.51 | 42.29 | 52.39 |
Employee costs | -250.79 | -234.03 | -205.15 | -146.53 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | -86.74 | 65.64 | -63.81 | -121.55 |
Depreciation | -83.18 | -75.89 | -71.08 | -45.04 |
Tax paid | 31.31 | -11.56 | 7.49 | 0.14 |
Working capital | 139.57 | -55.07 | -268.15 | 642.72 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -16.1 | 24.21 | 35.19 | 16.19 |
Op profit growth | -145.62 | -205.35 | -33.48 | 134.8 |
EBIT growth | -226.48 | -207.06 | -47.18 | 31.19 |
Net profit growth | -202.49 | -196.03 | -102.2 | 2,361.41 |
| Particulars (Rupees in Crores.) | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
Gross Sales | 2,201.85 | 2,110.97 | 1,785.11 | 1,343.02 | 1,269.83 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 2,201.85 | 2,110.97 | 1,785.11 | 1,343.02 | 1,269.83 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 264.92 | 35.32 | 31.59 | 38.52 | 47.51 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,951.5 | 159.12 | 4,68,458.16 | 608.7 | 0.82 | 4,887.27 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 7,273 | 72.64 | 1,93,383.24 | 756 | 0.41 | 2,793 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 5,017.8 | 76.76 | 1,69,828.54 | 467 | 0.76 | 2,677 | 249.73 |
Cipla Ltd CIPLA | 1,438 | 33.75 | 1,16,164.12 | 384.64 | 0.9 | 3,840.92 | 423.36 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,156.9 | 31.2 | 1,15,151.84 | 1,722 | 0.09 | 3,564.6 | 237.3 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman(Non Exe)&Dir(Non-Ind)
Prakash A Mody
Managing Director & CEO
Pabitra Bhattacharya
Non-Exec & Non-Independent Dir
Pranay Godha
Independent Non Exe. Director
Anand T Kusre
Independent Non Exe. Director
Arun Todarwal
Independent Non Exe. Director
Swati Patankar
HEAD - LEGAL / CS / CHIEF COMPLIANCE OFFICER
Pradeep Bhandari
47 Kandivli Industrial Estate,
Kandivli (West),
Maharashtra - 400067
Tel: 91-22-66474100
Website: http://www.unichemlabs.com
Email: shares@unichemlabs.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: https://in.mpms.mufg.com
Email: rnt.helpdesk@in.mpms.mufg.com
Summary
Unichem Laboratories Limited manufactures active pharmaceutical ingredients. The company operates through four divisions, namely Unichem Pharma Division, Unichem Specialities Division, Unisearch Divis...
Read More
Reports by Unichem Laboratories Ltd
What is the Unichem Laboratories Ltd share price today?
What is the Market Cap of Unichem Laboratories Ltd?
What is the PE and PB ratio of Unichem Laboratories Ltd?
What is the 52 Week High and Low of Unichem Laboratories Ltd?
What is the CAGR of Unichem Laboratories Ltd?
What is the shareholding pattern of Unichem Laboratories Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
